Adaptive Biotechnologies Corp (ADPT) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2017: $2.42M2018: $6.30M2019: $11.20M2020: $18.80M2021: $61.75M2022: $16.35M2023: $10.70M2024: $3.66M2025: $2.96M$2.96M
2017Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$2.96M-19.2%
2024$3.66M-65.7%
2023$10.70M-34.6%
2022$16.35M-73.5%
2021$61.75M+228.4%
2020$18.80M+67.9%
2019$11.20M+77.8%
2018$6.30M+160.2%
2017$2.42M